Drawing for ETIL

USPTO serial 88201425

ETIL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GAYNOR, BARBARA ANNE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ETIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Nucleic acids for medical use; Kits composed primarily of nucleic acids, for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 5, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 4, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 12, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 12, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 12, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 15, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 15, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 15, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 15, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 15, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2021EX5GSOU EXTENSION 5 GRANTED—
Nov 29, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 18, 2021EXT5SOU EXTENSION 5 FILED—
Nov 18, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 26, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 24, 2021EX4GSOU EXTENSION 4 GRANTED—
May 24, 2021EXT4SOU EXTENSION 4 FILED—
May 24, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 1, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2020EX3GSOU EXTENSION 3 GRANTED—
Nov 29, 2020EXT3SOU EXTENSION 3 FILED—
Nov 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 23, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 21, 2020EX2GSOU EXTENSION 2 GRANTED—
May 21, 2020EXT2SOU EXTENSION 2 FILED—
May 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 22, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 20, 2019EXT1SOU EXTENSION 1 FILED—
Nov 20, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 28, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 2, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 22, 2019DOCKASSIGNED TO EXAMINER—
Dec 10, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 28, 2018TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Nov 28, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 23, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance